Guanfacine for Children
Links shared publicly online about this topic
INTUNIV (Guanfacine) drug information from MPR
empr.com — “INTUNIV (Guanfacine) drug information for ADD, ADHD {ADHD} from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on April 13, 2011 at 4:19 am By:
MPR News: INTUNIV: Indications: approved as adjunctive therapy. Children: adjunctive therapy dosing added. http://bit.ly/dTFdne
Guanfacine, psychostimulants improved ADHD symptoms in children, adolescents
pediatricsupersite.com — “Guanfacine XR, a selective alpha-2A agonist approved for treating attention-deficit/hyperactivity disorder, significantly improved symptoms in c” View full resource at pediatricsupersite.com
Most Recently Shared on May 28, 2010 at 4:08 am By:
Peter H Brown Doctor and Psychologist
Guanfacine, psychostimulants improved ADHD symptoms in children, adolescents http://bit.ly/bgnxoB #ADHD
INTUNIV (Guanfacine) Extended Release Tablets For ADHD In Children And Adolescents Approved By FDA
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV™ (” View full resource at medicalnewstoday.com
Most Recently Shared on September 5, 2009 at 12:05 pm By:
MNT Pediatrics News Health News and Pediatrics
INTUNIV (Guanfacine) Extended Release Tablets For ADHD In Children And Adolescents Approved By FDA: Shire plc (L.. http://bit.ly/2IQcHz
News - Guanfacine Plus Stimulants Improves Symptom Management in Children With ADHD: Presented at APA
docguide.com — “Guanfacine Plus Stimulants Improves Symptom Management in Children With ADHD: Presented at APA” View full resource at docguide.com
Most Recently Shared on May 26, 2010 at 12:03 am By:
Peter H Brown Doctor and Psychologist
Guanfacine Plus Stimulants Improves Symptom Management in Children With ADHD ... http://bit.ly/br20Dl #ADHD
FDA approves guanfacine ER tablets to treat ADHD in children, teens - - Drug Topics
drugtopics.modernmedicine.com — “FDA approved the use of once-daily guanfacine (Intuniv, Shire) extended-release tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder in children and adolescents aged 6 to 17 years as part of a total treatment program.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on March 2, 2011 at 7:52 pm By:
FDA approves guanfacine ER tablets to treat ADHD in children, teens: FDA approved the use of once-daily gu... http://bit.ly/hRwbtM #adhd
Shire Announces FDA Approval of Once-Daily Intuniv (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
drugs.com — “Intuniv (guanfacine) is used to treat Attention-Deficit/Hyperactivity Disorder in children and adolescents aged 6 to 17 years. Includes Intuniv side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 4, 2009 at 12:32 am By:
FDA Approves Intuniv (guanfacine) for the Treatment of ADHD in Children and Adolescents - http://bit.ly/EObbC
Medical News: APA: Guanfacine Helps as Add-On for ADHD - in Meeting Coverage, APA from MedPage Today
medpagetoday.com — “HONOLULU -- Whether given in the morning or at bedtime, extended-release guanfacine (Intuniv) added to stimulant medications for attention deficit-hyperactivity disorder (ADHD) in children and teens i” View full resource at medpagetoday.com
Most Recently Shared on May 20, 2011 at 8:46 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday APA: Guanfacine Helps as Add-On for ADHD (CME/CE) http://bit.ly/mrn4ya #medical #Health
Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents - MarketWatch
marketwatch.com — “Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on May 21, 2010 at 3:43 pm By:
Peter H Brown Doctor and Psychologist
Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets Co ... http://bit.ly/dliH5l #ADHD
FDA approves extended-release guanfacine (Intuniv®) as an adjunctive therapy to stimulants for the treatment of ADHD in children and adolescents - NeLM [2.1.9]
nelm.nhs.uk — “FDA approves extended-release guanfacine (Intuniv®) as an adjunctive therapy to stimulants for the treatment of ADHD in children and adolescents - NeLM [2.1.9]” View full resource at nelm.nhs.uk
Most Recently Shared on March 1, 2011 at 8:33 pm By:
FDA approves extended-release guanfacine (Intuniv®) as an adjunctive therapy to stimulants for the treatm... http://bit.ly/gF8pqX #adhd
PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
pharmalive.com — “PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents” View full resource at pharmalive.com
Most Recently Shared on February 28, 2011 at 7:27 pm By:
PharmaLive Health News and Pharma
Daily Advantage - FDA OKs Wider Intuniv Use - http://tinyurl.com/4on7zsc
APA: Guanfacine Helps as Add-On for ADHD (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “HONOLULU (MedPage Today) -- Whether given in the morning or at bedtime, extended-release guanfacine (Intuniv) added to stimulant medications for attention deficit-hyperactivity disorder (ADHD) in children and teens improved symptom control, a researcher said here.” View full resource at qualitypointtech.net
Most Recently Shared on May 20, 2011 at 8:45 pm By:
APA: Guanfacine Helps as Add-On for ADHD (CME/CE): HONOLULU (MedPage Today) -- Whether given in the morning or at ... http://bit.ly/mORZse
Investigational Data Presented for INTUNIV (guanfacine) Extended-Release Tablets When Coadministered With Stimulants Showed ADHD Symptom Improvement in Overall, Morning and Evening Assessments - Drugs.com MedNews
drugs.com — “Shire plc (LSE SHP, Nasdaq SHPGY), the global specialty biopharmaceutical company, today presented research results of once-daily INTUNIV (guanfacine) Extended-” View full resource at drugs.com
Most Recently Shared on October 28, 2010 at 4:15 pm By:
Drugs and Devices OW OW Health
Investigational Data Presented for INTUNIV (guanfacine) Extended-Release Tablets When Coadministered With Sti... http://bit.ly/9aEmxf #drug
Family Medicine News & Articles - MDLinx - Attention Deficit Disorder with Hyperactivity on #MDlinx
mdlinx.com — “Family Medicine News & Articles - MDLinx - Attention Deficit Disorder with Hyperactivity on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 8, 2010 at 3:41 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6-12 Years with Attent... http://bit.ly/b34zTb #GM #mdlinx
Adjunctive therapy for ADHD approved
pediatricsupersite.com — “The FDA has approved once-daily guanfacine as adjunctive therapy for the treatment of attention-deficit/hyperactivity disorder in children and a” View full resource at pediatricsupersite.com
Most Recently Shared on March 3, 2011 at 8:13 pm By:
Pediatric SuperSite Health Site
Adjunctive therapy for ADHD approved http://ow.ly/47pC1
Coadministration of INTUNIV tablets with stimulant reduces ADHD symptoms
news-medical.net — “Shire plc the global specialty biopharmaceutical company, today presented research results of once-daily INTUNIV (guanfacine) Extended-Release Tablets, coadministered with stimulants in children and adolescents diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) who had suboptimal response to treatment with a long-acting stimulant alone.” View full resource at news-medical.net
Most Recently Shared on October 29, 2010 at 8:59 am By:
Coadministration of INTUNIV tablets with stimulant reduces ADHD symptoms: Shire plc the global specialty biopharma... http://bit.ly/cWdVK9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
MNT Pediatrics News
The latest pediatrics / children's health news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
